Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
13,621
datasets available to search
ShareScore release 0.9.0
Dataset results
13,621 results for “Biologics”
Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly
ClinicalTrials.gov study NCT00968890. IPD Sharing: YES. Countries: 1. Publications: 1.
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
ClinicalTrials.gov study NCT01702454. IPD Sharing: YES. Countries: 4. Publications: 1.
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine
ClinicalTrials.gov study NCT01021293. IPD Sharing: YES. Countries: 1. Publications: 1.
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)
ClinicalTrials.gov study NCT01910519. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
ClinicalTrials.gov study NCT00964158. IPD Sharing: YES. Countries: 1. Publications: 2.
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
ClinicalTrials.gov study NCT00578175. IPD Sharing: YES. Countries: 1. Publications: 1.
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boost
ClinicalTrials.gov study NCT00489970. IPD Sharing: YES. Countries: 1. Publications: 2.
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults
ClinicalTrials.gov study NCT01416571. IPD Sharing: YES. Countries: 1. Publications: 1.
Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older
ClinicalTrials.gov study NCT00753272. IPD Sharing: YES. Countries: 15. Publications: 3.
Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine
ClinicalTrials.gov study NCT00635128. IPD Sharing: YES. Countries: 1. Publications: 2.
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
ClinicalTrials.gov study NCT01165203. IPD Sharing: YES. Countries: 3. Publications: 1.
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
ClinicalTrials.gov study NCT00802464. IPD Sharing: YES. Countries: 3. Publications: 1.
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers
ClinicalTrials.gov study NCT01340898. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
ClinicalTrials.gov study NCT01165177. IPD Sharing: YES. Countries: 18. Publications: 13.
Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) St
ClinicalTrials.gov study NCT02690207. IPD Sharing: YES. Countries: 18. Publications: 1.
Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease
ClinicalTrials.gov study NCT00861380. IPD Sharing: YES. Countries: 1. Publications: 9.
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
ClinicalTrials.gov study NCT01248884. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)
ClinicalTrials.gov study NCT03679676. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.
ClinicalTrials.gov study NCT00412854. IPD Sharing: YES. Countries: 1. Publications: 0.
Biological Sample Repository for Gastrointestinal Disorders
ClinicalTrials.gov study NCT05874726. IPD Sharing: YES. Countries: 1. Publications: 15.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.